Cencora | COR - Cost Of Sales

Stock Price
330.88
Daily Change
5.70 1.75%
Monthly
-8.36%
Yearly
23.54%
Q1 Forecast
339.38

Cencora reported $83.12B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Ambu A/S DKK 611M 24M Dec/2025
Amplifon EUR 460.17M 14.78M Sep/2025
Apollo Hospitals Enterprise Ltd INR 36.02B 1.4B Dec/2025
Avanos Medical USD 94.9M 3.1M Dec/2025
Brookdale Senior Living USD 643.31M 41M Dec/2025
Cencora USD 83.12B 2.35B Dec/2025
Coloplast 2.31B 110M Dec/2025
Convatec Group USD 515.3M 270.15M Dec/2024
Diasorin EUR 99.64M 4.71M Sep/2025
Encompass Health USD 150.9M 3.9M Dec/2025
Enovis USD 271.52M 7.83M Dec/2025
GE HealthCare Technologies USD 3.44B 283M Dec/2025
Gulf Medical Proj AED 151.05M 11.52M Dec/2025
Hoya 33.74B 138.33B Dec/2025
Med Life RON 283.78M 123.71M Sep/2025
Oriola-kd EUR 426.1M 25.5M Sep/2025
Rede D'or Sao Luiz BRL 11.05B 13.46M Sep/2025
Siemens Healthineers EUR 3.33B 622M Dec/2025
Solventum Corp USD 971M 8M Dec/2025
Sonova Holding CHF 539.4M 11.5M Dec/2025
Veradigm USD 124.74M 56.25M Dec/2022
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025